%D8%A5%D9%83%D9%8A%D9%86%D9%88%D9%83%D8%A7%D9%86%D8%AF%D9%8A%D9%86EchinocandinEquinocandinas%D8%A7%DA%A9%DB%8C%D9%86%D9%88%DA%A9%D8%A7%D9%86%D8%AF%DB%8C%D9%86%C3%89chinocandineEchinocandineEquinocandina%D0%AD%D1%85%D0%B8%D0%BD%D0%BE%D0%BA%D0%B0%D0%BD%D0%B4%D0%B8%D0%BD%D1%8BEhinokandin%D0%95%D1%85%D1%96%D0%BD%D0%BE%D0%BA%D0%B0%D0%BD%D0%B4%D0%B8%D0%BD%D0%B8Q3718510
about
Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematologyA Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive CandidiasisA Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive AspergillosisCaspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell TransplantCaspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal InfectionOptimal Dosage of Caspofungin in Critically Ill PatientsMicafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant RecipientsPharmacokinetics of Caspofungin After One Dose in Patients With Liver FailureStudy of Innate Host Immune Response to C. Glabrata Clinical Isolates Resistant to Echinocandins: Impact on the Management of Candidemia in High-risk PatientsComparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With MicafunginEchinocandins Versus Azoles for Candidemia Treatment
P4844
Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.Combination antifungal therapy for treatment of prosthetic valve endocarditis and utility of T2Candida Panel®: A case seriesTwo-stage revision and systemic antifungal therapy of Candida glabrata primary prosthetic hip infection successfully treated: a case report
P921
Q61894605-2245708C-6A50-4B43-A9B9-DC02B21539E8Q61915392-EC349673-5893-44AB-AFDA-E81C768176A1Q61917506-0B000FED-5F28-42C8-B616-A131053EE170Q61921710-67BD33FE-A215-4054-95B2-9306D442FE12Q61957400-1CF00FD0-4128-4E3F-8501-228E3B6D12FFQ61957562-A89653FF-D7E3-4DA0-995A-6002B6FB456FQ61969803-1D6B33A5-5C9B-4AD5-86B2-C4045FCC645EQ61975043-16B3520C-445A-46FF-9725-59B2B18A6E1CQ61975517-4075EEDF-8C60-4C74-B68B-AF35D552EBD3Q62025278-E89E6AC5-C027-4ECD-9ECF-29ECA84FE9E9Q63576210-AD61C09E-208E-40DD-801F-DF08A56ACFBFQ63591850-074B877C-FA17-49AB-A964-C26AA27D2236
P4844
description
group of chemical compounds
@en
grupa związków chemicznych
@pl
name
Echinocandin
@nl
Echinocandine
@it
Ehinokandin
@sl
Equinocandina
@pt
Equinocandinas
@es
echinocandin
@en
echinokandyna
@pl
Échinocandine
@fr
Ехінокандини
@uk
Эхинокандины
@ru
type
label
Echinocandin
@nl
Echinocandine
@it
Ehinokandin
@sl
Equinocandina
@pt
Equinocandinas
@es
echinocandin
@en
echinokandyna
@pl
Échinocandine
@fr
Ехінокандини
@uk
Эхинокандины
@ru
altLabel
echinocandins
@en
echinokandyny
@pl
棘白菌素系列藥物
@zh
prefLabel
Echinocandin
@nl
Echinocandine
@it
Ehinokandin
@sl
Equinocandina
@pt
Equinocandinas
@es
echinocandin
@en
echinokandyna
@pl
Échinocandine
@fr
Ехінокандини
@uk
Эхинокандины
@ru
P486
P6366
P683
P373
Echinocandins
P486
P6366
2779320740
P7830
Echinocandins